Browse News

Found 733,877 articles

• 

  Theranos’ Epic Self-Destruction Offers Lessons for Biotech Companies

  8/3/2022

  Whistleblowers Erika Cheung and Tyler Shultz discussed their experiences at Theranos during the recent 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.

• Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya

  8/3/2022

  Vela Diagnostics has announced its appointment by the National Public Health Laboratory of Kenya as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund.

• Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of RLF-100(R) (Aviptadil)

  8/3/2022

  RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic benefit from serious diseases with high unmet need, announced promising three-month stability data on a new formulation of RLF-100®.

• Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines

  8/3/2022

  Jiangsu Recbio Technology Co., Ltd. is pleased to announce that, the Company has recently received the clinical trial approval for its recombinant protein COVID-19 vaccine, ReCOV from the Food and Drug Administration of the Philippines.

• Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer

  8/3/2022

  Ipsen announced that the Phase III RESILIENT trial did not meet its primary endpoint of overall survival compared to topotecan.

• Pixium Vision announces regulatory approval of remote rehabilitation system for patients in clinical trials

  8/3/2022

  Pixium Vision SA, a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces the approval of the remote rehabilitation system for patients enrolled in the PRIMAvera pivotal trial and the French Feasibility Study in atrophic dry age-related macular degeneration.

• Axonics® Announces Pricing of Public Offering of Common Stock - Aug 03, 2022

  8/3/2022

  Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that it priced its previously announced underwritten public offering of 1,750,000 shares of its common stock.

• Arcutis Biotherapeutics Announces Pricing of Public Offering of Common Stock

  8/3/2022

  Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced the pricing of its underwritten public offering of 7,500,000 shares of its common stock at a public offering price of $20.00 per share, representing a premium to the closing price of $19.50 per share on August 2, 2022.

• Mainz Biomed Appoints Former QIAGEN Executive Dr. Frank Krieg-Schneider as Vice President of Development

  8/3/2022

  Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the appointment of Dr.

• Burning Rock Announces 2022 Annual General Meeting to be Held on September 8, 2022

  8/3/2022

  Burning Rock Biotech Limited, a company focusing on the application of next generation sequencing technology in the field of precision oncology, announced that it will hold its annual general meeting on September 8, 2022 at 10:00 a.m. at the Company’s Shanghai office at 5/F, Building 1, No. 138 Xinjunhuan Road, Minhang District, Shanghai.

• Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

  8/3/2022

  Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with vascular and coronary artery disease, today reported financial results for its fourth quarter and full year, ended June 30, 2022.

• Single-use Bioprocessing Systems Market Trends, Applications, Competitive Landscape and Regional Insights to 2028

  8/3/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc.: Single-use systems are biopharmaceutical manufacturing equipment that are designed to be utilized once and then disposed off.

• Platelet-rich Plasma Market: Rise in Emphasis on Post-Surgical Repairs Drives Market

  8/3/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc.: This report analyzes the current scenario and future prospects of the global platelet rich plasma market.

• Orthopedic Devices Market: Surge in Adoption of Technologically Advanced Products to Drive the Market

  8/3/2022

  According to Transparency Market Research’s latest report on the global orthopedic devices market for the historical period 2017–2018 and forecast period 2019–2027, rise in percentage of population requiring orthopedic devices, increase in incidence rates of injuries related to accidents, sports, and adventure, surge in adoption of technologically advanced products are projected to drive the global orthopedic devices market during the forecast period.

• Oncology Nutrition Market: Global Demand Expanding at a Profitable Compound Annual Growth Rate (CAGR) Forecast, 2031

  8/3/2022

  Oncology makes for a field that is consistently evolving owing to great amount of research and development activities are currently underway to formulate therapies and drugs to treat tumors that cause cancer as well as emerge as a result of chemotherapies.

• Neurological Biomarkers Market, Outlook 2031 | Proactive Government Initiatives and Rising Funding for the Diagnosis of Neurological Disorders

  8/3/2022

  The neurological biomarkers market is anticipated to grow on the back of the increasing count of psychiatric and neurological disorders during the upcoming years.

• Nerve Repair and Regeneration Market Insights [Size | Share | Trends | Growth] | Global Industry Analysis, 2031

  8/3/2022

  The growth opportunities in the nerve repair and regeneration market are growing at a noticeable speed due to numerous factors.

• Market Players Capitalizing On Online Training Are Expected To Support The Growth Of Medical Education Market By 4.2% CAGR During Forecast Period.

  8/3/2022

  Surge in advancements in healthcare infrastructure has boosted investments in medical education.

• Testosterone Replacement Therapy Market: Increasing Incidence of Testosterone Deficiency to Drive the Market

  8/3/2022

  According to Transparency Market Research’s latest report on the global testosterone replacement therapy market for the historical period 2017–2018 and forecast period 2019–2027, increasing incidence of testosterone deficiency, growing awareness among people regarding testosterone replacement therapy and significant pipeline of medications, are projected to drive the global testosterone replacement therapy market during the forecast period

• Medical Laboratories Market Analysis of Current Trends and Future Aspects from 2020 to 2030

  8/3/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc.: The demand within the global medical laboratories market is slated to multiply over the next decade.